Managing urosepsis with a novel BL + BLI: A case report
1 Department of Medicine Govt Medical College, Datia.
2 Department of Pathology M.L.B Medical college Jhansi.
Review
International Journal of Biological and Pharmaceutical Sciences Archive, 2022, 03(01), 021–023.
Article DOI: 10.53771/ijbpsa.2022.3.1.0022
Publication history:
Received on 10 December 2021; revised on 18 January 2022; accepted on 20 January 2022
Abstract:
The rising resistance to Enterobacteriaceae to first-line antibiotics in treating cases of Complicated UTI (cUTI) is a serious challenge. With the rapid spread of strains producing Extended-spectrum beta-lactamases (ESBLs), few options remain in treating cases of the complicated urinary tract, especially ESBL producing E. coli, leading to urosepsis. In our case, the patient was successfully treated for ESBL, producing E. coli with Supime (cefepime+ sulbactam).
Keywords:
ESBLs; cUTI; Urosepsis; Supime; Cefepime + sulbactam; E. coli
Full text article in PDF:
Copyright information:
Copyright © 2021 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0